Barely Significant
← all excerpts

Lorcaserin for weight management.

Diabetes Metab Syndr Obes · 2013 · PMC3684144 · PMID 23788837

Europe PMCDOI
1
hedged sentence
0.2600
closest p · 5.2× alpha
0.2600
boldest claim

The sentences

did not reach statistical significanceP = 0.26not close (p > 0.1)
After one year of treatment, scores were lower in the lorcaserin group compared with the placebo group (1.1 ± 0.1 versus 0.9 ± 0.1, respectively), although the difference did not reach statistical significance ( P = 0.26). 21 A large discontinuation rate of nearly 50% was reported in the BLOOM trial, with a rate of completion of 55.4% in the lorcaserin group and 45.1% in the placebo group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.